Tally Health Raises $10M in Seed Funding

Tally Health, a New York-based consumer biotechnology company, raised $10M in Seed funding.

The round was led by Forerunner Ventures, with participation from Catterton, which incubated and initially backed the company, G9 Ventures and Second Sight Ventures. In addition, celebrities including John Legend, Chrissy Teigen, Pedro Pascal, Shonda Rhimes, Kevin Hart, Rich Roll, Whitney Cummings, and Zac Efron have individually invested in the company.

The company intends to use the funds to support its expand research and development of new products, additional features, and technology integrations to allow users to integrate their TallyAge feedback into their daily lifestyle through the digital member experience. Funds will also be allocated toward various technical, business, and strategic development efforts as the company scales.

Led by CEO Melanie Goldey, Tally is a consumer biotechnology company that provides a proprietary diagnostic test and individualized interventions give members the science-backed tools, which aim to improve healthspan and extend longevity at the cellular level with TallyAge epigenetic age tests, personalized lifestyle recommendations, and research-backed longevity supplements.